ENCOMPASS HEALTH REHABILITATION HOSP — History
CCN 103033 | 3-year financial timeline | COVID resilience: 65/100
🛡️ Public data only — no PHI permitted on this instance.
$23M
Latest Revenue (FY2022)
+4.4%
Revenue CAGR (3yr)
11.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $21M | $23M | $23M | -0.1% | +4.4% |
| Operating Expenses | $20M | $21M | $20M | -4.0% | +1.1% |
| Operating Margin | 6.0% | 8.3% | 11.8% | +42.4% | +40.7% |
| Net Income | $1M | $2M | $3M | +42.2% | +46.9% |
| Licensed Beds | 76 | 76 | 76 | +0.0% | +0.0% |
| Total Patient Days | 15,005 | 15,753 | 14,957 | -5.1% | -0.2% |
| Medicare Day % | 66% | 66% | 66% | +0.9% | +0.7% |
| Medicaid Day % | 0% | 0% | 0% | -78.1% | +0.2% |
COVID Impact & Recovery
Resilience Score: 65/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +9.0% ($21M → $23M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.4%
This Hospital
+7.6%
State Avg
Latest Margin
11.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $24M | 14.8% |
| FY2024 (proj) | $25M | 17.7% |
| FY2025 (proj) | $26M | 20.6% |